C. Weyer et al., Insulin action and insulinemia are closely related to the fasting complement C3, hot not acylation stimulating protein concentration, DIABET CARE, 23(6), 2000, pp. 779-785
OBJECTIVE - An elevated C3 concentration has been reported in people with o
besity type 2 diabetes, hypertension, and dyslipidemia, and has been propos
ed to play a role in the development of atherosclerosis. We hypothesized th
at an elevated C3 concentration might be linked to insulin resistance and/o
r hyperinsulinemia, abnormalities commonly observed in association with the
above conditions.
RESEARCH DESIGN AND METHODS - Fasting concentrations of C3 and acylation st
imulating protein (ASP, C3adesarg), a cleavage product of C3 recently found
to stimulate glucose uptake in vitro, were measured in 33 healthy nondiabe
tic Pima Indians (14 women and 19 men; age 27 +/- 1 and body fat 33 +/- 1%,
means +/- SEM). Subjects were characterized for body composition dual-ener
gy X-ray absorptiometry insulin action (insulin-stimulated glucose disposal
[M], hyperinsulinemic glucose clamp), and glucose tolerance (75-g oral glu
cose tolerance test).
RESULTS - Fasting C3 and ASP concentrations were positively correlated (r =
0.43, P < 0.05). Fasting C3 concentration was closely related to percent b
ody fat (r = 0.77), M (r = -0.75), and lasting insulin concentration (r = 0
.72) (all P < 0.0001). Fasting C3 concentrations remained significantly rel
ated to M and lasting insulin after adjusting for percent body fat (partial
r = -0.53 and 0.33, both P < 0.05). In subjects with impaired glucose tole
rance, fasting C3 concentrations were higher than in those with normal gluc
ose tolerance-a difference that remained after adjustment for percent body
fat and M. We found that fasting ASP concentrations were significantly rela
ted to percent body fat (r = 0.37. P < 0.05), but not to M or fasting insul
in.
CONCLUSIONS - In Pima Indians, fasting C3 concentration is closely related
to adiposity insulin action, and lasting insulin levels and may thus be a m
ediator for the postulated link between obesity insulin resistance, hyperin
sulinemia, and possibly atherosclerosis.